Skip to main content
Market intelligence
GKOSHealthcare

Glaukos Corporation insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 5, 2026Tomas NavratilCHIEF DEVELOPMENT OFFICERSale1,527$164.45$251,120
Sep 25, 2026Tomas NavratilCHIEF DEVELOPMENT OFFICERSale1,615$154.28$249,158
Sep 16, 2026Tomas NavratilCHIEF DEVELOPMENT OFFICERSale1,457$166.92$243,204